Salvatore Funiciello

Medical Director @Zogenix, Inc

Rome, IT
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2019 — Present

Medical Director @Zogenix, Inc

View department →

Roma, IT

EDUCATION

1994 — 1998

Sapienza Università di Roma

Post Graduate/PhD/Specialization

1993 — 1994

Sapienza Università di Roma

National Examination

2004 — 2005

Orphan Europe Education Programme

Orphan Drug Specialist Education Programme

1987 — 1992

Sapienza Università di Roma

BD Biological Sciences Degree

SKILLS

HospitalsMarket AccessTherapeutic AreasPharmaceutical SalesProduct LaunchLifesciencesInfectious DiseasesLife SciencesClinical TrialsNeurologyOncologyRheumatologyCardiologyGastroenterologyPharmaceutical IndustryNegotiationBiotechnology

ABOUT SALVATORE FUNICIELLO

Medical Affair management, Kol’s management, Medical Information and Clinical Research, actually in severe Epileptic Encephalopathies: Dravet Syndrome and Lennox Gastaut Syndrome. Country Product Management, business plan management, Medical Sales Project Management, Team Management, Senior Experience in Orphan Drugs and rare Diseases at all levels of engagement. Key Account Management, Senior Product Specialist, Scientific Specialist. Expert in developing and maintaining strong relationships with national, regional and local KOL’s and Scientific Societies in the therapeutic area of interest. Speaker at congress, expert meetings and hospital meetings. Effective medical affair support for the definition and implementation of clinical and observational trials in Italy (IIR and CSS). Multi tasking and organizational agility. Scouting expertise. Communication and strong intrapersonal skills with an ability to work at high level. Senior professional presence and credibility, passionate and self-confident. High grade technology specialty management. New start up expertise. Expert on national, regional and local market access PTOR/PTAV/PTO Key products launched: CARBAGLU (Carglumic Acid), PEDEA (Ibuprofen I.V.), ADAGEN (Pegademase Bovine), CYSTADANE (Betaine Anhydrous), WILZIN (Zinc Acetate), ORFADIN (Nitisinone), DUODOPA (Levodopa/Carbidopa Intestinal Gel), AMMONAPS (Sodium Phenylbutyrate), CYSTAGON (Cysteamine Bitartrate), NORMOSANG, VEDROP,COSMEGEN, AERUGEN, etc…. Expertise: Therapeutic Areas Managed: Rare Diseases, Pediatrics, Neonatal Intensive Care, Hematology, Pain, Anesthesia, Intensive Care Units, Neurology, Lung Diseases, Cardiology, Gynecology, Emergency Room. Investigate, select and performing activities with the scenario, targets, demographic and market knowledge National territory management National Market Access and PTOR/PTAV/PTO (regional and local formularies) management

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Salvatore Funiciello — Medical Director at Zogenix, Inc in Rome, IT | Unifers